CGTX: Cognition Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 28.33
Enterprise Value ($M) 6.50
Book Value ($M) 14.48
Book Value / Share 0.35
Price / Book 1.96
NCAV ($M) 13.73
NCAV / Share 0.33
Price / NCAV 2.06

Profitability (mra)
Return on Invested Capital (ROIC) -2.25
Return on Assets (ROA) -0.97
Return on Equity (ROE) -1.40

Liquidity (mrq)
Quick Ratio 2.11
Current Ratio 2.11

Balance Sheet (mrq) ($M)
Current Assets 26.83
Assets 27.58
Liabilities 13.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-07 13G/A Hirschman Orin 4.80 -28.93
2024-01-19 13G Pathstone Family Office, Llc 7.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 144,422 471,759 30.61
2025-01-17 164,711 588,457 27.99
2025-01-16 81,136 413,648 19.61

(click for more detail)

Similar Companies
BTMD – biote Corp. CADL – Candel Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc. CHRS – Coherus BioSciences, Inc.
CLSD – Clearside Biomedical, Inc.


Financial data and stock pages provided by
Fintel.io